Categorization of topoisomerase targeting anticancer drugs
Drug mechanisms and classification | Class-I (topoisomerase poisons) | Class-II (topoisomerase inhibitors) |
---|---|---|
Mechanism of drug action | These drugs act as intermediaries in the catalytic cycle of the enzyme, blocking the creation of a covalent topoisomerase-DNA network. | These medications interfere with the enzyme’s catalytic action without trapping the covalent compound. |
Nomenclature and classification of drug types | Class-I medications are sometimes referred to as “topoisomerase poisons” since they convert the enzyme into a strong cellular toxin. | Class-II drugs are assigned as “topoisomerase inhibitors.” |
Varieties of topoisomerase medications | Class-I medications contain acridines, alkaloids, anthracyclines, ellipticines, epipodophyllotoxins, actinomycin, quinolones, and isoflavonoids. | Class-II medications are fostriecin analogues and coumarin antibiotics. |